Ad-hoc | 5 November 2025 17:56

SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO

SCHOTT Pharma AG & Co. KGaA / Key word(s): Personnel
SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO

05-Nov-2025 / 17:56 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The Supervisory Board of SCHOTT Pharma Management AG has today appointed Christian Mias as the new Chief Executive Officer (CEO) of SCHOTT Pharma, effective May 1, 2026. He will succeed Andreas Reisse, who will retire as planned at the end of April 2026. Christian Mias has held various management positions within the SCHOTT Group since 2007, most recently serving as Head of the Business Unit Electronic Packaging.

End of Inside Information

05-Nov-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News

Language:	English
Company:	SCHOTT Pharma AG & Co. KGaA
	Hattenbergstraße 10
	55122 Mainz
	Germany
ISIN:	DE000A3ENQ51
WKN:	A3ENQ5
Indices:	SDAX
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID:	2224602

End of Announcement EQS News Service

2224602  05-Nov-2025 CET/CEST